PHILADELPHIA, October 5, 2016: Morgan Lewis recently represented Tabula Rasa HealthCare, Inc. in its $60 million initial public offering (IPO). The closing of Tabula Rasa’s IPO of 4,945,000 million shares of common stock at $12 per share, which included the exercise in full by the underwriters of their option to purchase up to 645,000 additional shares of common stock, occurred October 4.
Tabula Rasa’s common stock is listed on the Nasdaq Global Market under the ticker symbol TRHC. Tabula Rasa estimates net proceeds from the offering to be approximately $51.6 million, after deducting underwriting discounts and commissions, and estimated offering expenses.
Tabula Rasa is a leading provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk.
The Morgan Lewis team representing Tabula Rasa was led by Kevin Shmelzer and James McKenzie as well as by Stephen Goodman. Partners Jeffrey Bodle, Howard Young, Joyce Cowan, and Patrick Rehfield; senior attorney Sally Liao; and associates Kate Moll-Taylor, Lindsay Tarnowski, Crystal Fang, Josh Loftus, and Carly Grey also provided support.